{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:34:54Z","timestamp":1781037294417,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13760-024-02710-x","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T04:31:29Z","timestamp":1735533089000},"page":"435-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic values of serum levels of \u03b1-synuclein, homocysteine and leucine-rich \u03b12 glycoprotein for predicting cognitive impairment in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"125","author":[{"given":"Rongchuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"2710_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/mdc3.12956","volume":"7","author":"P Linortner","year":"2020","unstructured":"Linortner P, McDaniel C, Shahid M, Levine TF, Tian L, Cholerton B, Poston KL (2020) White Matter hyperintensities related to Parkinson\u2019s Disease Executive function. Mov Disord Clin Pract 7:629\u2013638. https:\/\/doi.org\/10.1002\/mdc3.12956","journal-title":"Mov Disord Clin Pract"},{"key":"2710_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Primers"},{"key":"2710_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano C, Barone P, Trojano L, Santangelo G (2020) Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: a meta-analysis. Mov Disord 35:45\u201354. https:\/\/doi.org\/10.1002\/mds.27902","journal-title":"Mov Disord"},{"key":"2710_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","volume":"70","author":"KF Pedersen","year":"2013","unstructured":"Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 70:580\u2013586. https:\/\/doi.org\/10.1001\/jamaneurol.2013.2110","journal-title":"JAMA Neurol"},{"key":"2710_CR5","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1002\/mds.23921","volume":"26","author":"IJ Posada","year":"2011","unstructured":"Posada IJ, Benito-Leon J, Louis ED, Trincado R, Villarejo A, Medrano MJ, Bermejo-Pareja F (2011) Mortality from Parkinson\u2019s disease: a population-based prospective study (NEDICES). Mov Disord 26:2522\u20132529. https:\/\/doi.org\/10.1002\/mds.23921","journal-title":"Mov Disord"},{"key":"2710_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"2710_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"PH Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K (2006) The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy. J Neural Transm (Vienna) 113:1435\u20131439. https:\/\/doi.org\/10.1007\/s00702-005-0427-9","journal-title":"J Neural Transm (Vienna)"},{"key":"2710_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/jnnp-2016-314857","volume":"88","author":"CH Lin","year":"2017","unstructured":"Lin CH, Yang SY, Horng HE, Yang CC, Chieh JJ, Chen HH, Liu BH, Chiu MJ (2017) Plasma alpha-synuclein predicts cognitive decline in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88:818\u2013824. https:\/\/doi.org\/10.1136\/jnnp-2016-314857","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2710_CR9","doi-asserted-by":"publisher","first-page":"BC01","DOI":"10.7860\/JCDR\/2015\/12545.5978","volume":"9","author":"V Gupta","year":"2015","unstructured":"Gupta V, Garg RK, Khattri S (2015) Serological analysis of alpha-synuclein and NF-kappaB in Parkinson\u2019s Disease patients. J Clin Diagn Res 9:BC01\u201304. https:\/\/doi.org\/10.7860\/JCDR\/2015\/12545.5978","journal-title":"J Clin Diagn Res"},{"key":"2710_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00702-012-0784-0","volume":"119","author":"B Mollenhauer","year":"2012","unstructured":"Mollenhauer B, Trautmann E, Otte B, Ng J, Spreer A, Lange P, Sixel-Doring F, Hakimi M, Vonsattel JP, Nussbaum R, Trenkwalder C, Schlossmacher MG (2012) Alpha-synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system. J Neural Transm (Vienna) 119:739\u2013746. https:\/\/doi.org\/10.1007\/s00702-012-0784-0","journal-title":"J Neural Transm (Vienna)"},{"key":"2710_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.12590","volume":"135","author":"AD Andersen","year":"2017","unstructured":"Andersen AD, Binzer M, Stenager E, Gramsbergen JB (2017) Cerebrospinal fluid biomarkers for Parkinson\u2019s disease - a systematic review. Acta Neurol Scand 135:34\u201356. https:\/\/doi.org\/10.1111\/ane.12590","journal-title":"Acta Neurol Scand"},{"key":"2710_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10072-019-03738-1","volume":"40","author":"A Bougea","year":"2019","unstructured":"Bougea A, Stefanis L, Paraskevas GP, Emmanouilidou E, Vekrelis K, Kapaki E (2019) Plasma alpha-synuclein levels in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. Neurol Sci 40:929\u2013938. https:\/\/doi.org\/10.1007\/s10072-019-03738-1","journal-title":"Neurol Sci"},{"key":"2710_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biochi.2020.02.015","volume":"173","author":"F Portillo","year":"2020","unstructured":"Portillo F, Vazquez J, Pajares MA (2020) Protein-protein interactions involving enzymes of the mammalian methionine and homocysteine metabolism. Biochimie 173:33\u201347. https:\/\/doi.org\/10.1016\/j.biochi.2020.02.015","journal-title":"Biochimie"},{"key":"2710_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/psyg.12483","volume":"20","author":"J Li","year":"2020","unstructured":"Li J, Gu C, Zhu M, Li D, Chen L, Zhu X (2020) Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson\u2019s disease. Psychogeriatrics 20:180\u2013188. https:\/\/doi.org\/10.1111\/psyg.12483","journal-title":"Psychogeriatrics"},{"key":"2710_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.parkreldis.2015.07.006","volume":"21","author":"P Costa-Mallen","year":"2015","unstructured":"Costa-Mallen P, Zabetian CP, Agarwal P, Hu SC, Yearout D, Samii A, Leverenz JB, Roberts JW, Checkoway H (2015) Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk. Parkinsonism Relat Disord 21:1087\u20131092. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.07.006","journal-title":"Parkinsonism Relat Disord"},{"key":"2710_CR16","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1073\/pnas.82.7.1906","volume":"82","author":"N Takahashi","year":"1985","unstructured":"Takahashi N, Takahashi Y, Putnam FW (1985) Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci U S A 82:1906\u20131910. https:\/\/doi.org\/10.1073\/pnas.82.7.1906","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2710_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/s0959-440x(01)00266-4","volume":"11","author":"B Kobe","year":"2001","unstructured":"Kobe B, Kajava AV (2001) The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11:725\u2013732. https:\/\/doi.org\/10.1016\/s0959-440x(01)00266-4","journal-title":"Curr Opin Struct Biol"},{"key":"2710_CR18","doi-asserted-by":"publisher","first-page":"e74453","DOI":"10.1371\/journal.pone.0074453","volume":"8","author":"M Miyajima","year":"2013","unstructured":"Miyajima M, Nakajima M, Motoi Y, Moriya M, Sugano H, Ogino I, Nakamura E, Tada N, Kunichika M, Arai H (2013) Leucine-rich alpha2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex. PLoS ONE 8:e74453. https:\/\/doi.org\/10.1371\/journal.pone.0074453","journal-title":"PLoS ONE"},{"key":"2710_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-7091-0923-6_20","volume":"113","author":"M Nakajima","year":"2012","unstructured":"Nakajima M, Miyajima M, Ogino I, Watanabe M, Hagiwara Y, Segawa T, Kobayashi K, Arai H (2012) Brain localization of leucine-rich alpha2-glycoprotein and its role. Acta Neurochir Suppl 113:97\u2013101. https:\/\/doi.org\/10.1007\/978-3-7091-0923-6_20","journal-title":"Acta Neurochir Suppl"},{"key":"2710_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00701-011-0963-z","volume":"153","author":"M Nakajima","year":"2011","unstructured":"Nakajima M, Miyajima M, Ogino I, Watanabe M, Miyata H, Karagiozov KL, Arai H, Hagiwara Y, Segawa T, Kobayashi K, Hashimoto Y (2011) Leucine-rich alpha-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 153:1339\u20131346 discussion 1346. https:\/\/doi.org\/10.1007\/s00701-011-0963-z","journal-title":"Acta Neurochir (Wien)"},{"key":"2710_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12883-019-1252-3","volume":"19","author":"CRA Silveira","year":"2019","unstructured":"Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH (2019) Ambroxol as a novel disease-modifying treatment for Parkinson\u2019s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol 19:20. https:\/\/doi.org\/10.1186\/s12883-019-1252-3","journal-title":"BMC Neurol"},{"key":"2710_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2147\/IJGM.S399307","volume":"16","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Li S, Wang S (2023) Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting mild cognitive impairment in Parkinson\u2019s Disease. Int J Gen Med 16:785\u2013792. https:\/\/doi.org\/10.2147\/IJGM.S399307","journal-title":"Int J Gen Med"},{"key":"2710_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"2710_CR24","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA (2013) The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84:1258\u20131264. https:\/\/doi.org\/10.1136\/jnnp-2013-305277","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2710_CR25","first-page":"S83","volume":"23","author":"D Fredericks","year":"2017","unstructured":"Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW (2017) Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: a perspective on the challenges, treatments, and economic burden. Am J Manag Care 23:S83\u2013S92","journal-title":"Am J Manag Care"},{"key":"2710_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349\u2013356. https:\/\/doi.org\/10.1002\/mds.24893","journal-title":"Mov Disord"},{"key":"2710_CR27","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707 quiz 1837. https:\/\/doi.org\/10.1002\/mds.21507","journal-title":"Mov Disord"},{"key":"2710_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cger.2020.01.001","volume":"36","author":"JG Goldman","year":"2020","unstructured":"Goldman JG, Sieg E (2020) Cognitive impairment and dementia in Parkinson Disease. Clin Geriatr Med 36:365\u2013377. https:\/\/doi.org\/10.1016\/j.cger.2020.01.001","journal-title":"Clin Geriatr Med"},{"key":"2710_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","volume":"72","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study G (2009) Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72:1121\u20131126. https:\/\/doi.org\/10.1212\/01.wnl.0000338632.00552.cb","journal-title":"Neurology"},{"key":"2710_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","volume":"75","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062\u20131069. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f39d0e","journal-title":"Neurology"},{"key":"2710_CR31","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1468-1331.2009.02707.x","volume":"16","author":"E Elgh","year":"2009","unstructured":"Elgh E, Domellof M, Linder J, Edstrom M, Stenlund H, Forsgren L (2009) Cognitive function in early Parkinson\u2019s disease: a population-based study. Eur J Neurol 16:1278\u20131284. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02707.x","journal-title":"Eur J Neurol"},{"key":"2710_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00702-016-1650-2","volume":"124","author":"J Ding","year":"2017","unstructured":"Ding J, Zhang J, Wang X, Zhang L, Jiang S, Yuan Y, Li J, Zhu L, Zhang K (2017) Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson\u2019s disease. J Neural Transm (Vienna) 124:353\u2013360. https:\/\/doi.org\/10.1007\/s00702-016-1650-2","journal-title":"J Neural Transm (Vienna)"},{"key":"2710_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1515\/CCLM.2005.191","volume":"43","author":"P Quadri","year":"2005","unstructured":"Quadri P, Fragiacomo C, Pezzati R, Zanda E, Tettamanti M, Lucca U (2005) Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 43:1096\u20131100. https:\/\/doi.org\/10.1515\/CCLM.2005.191","journal-title":"Clin Chem Lab Med"},{"key":"2710_CR34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1515\/CCLM.2001.120","volume":"39","author":"T Bertsch","year":"2001","unstructured":"Bertsch T, Mielke O, Holy S, Zimmer W, Casarin W, Aufenanger J, Walter S, Muehlhauser F, Kuehl S, Ragoschke A, Fassbender K (2001) Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 39:721\u2013724. https:\/\/doi.org\/10.1515\/CCLM.2001.120","journal-title":"Clin Chem Lab Med"},{"key":"2710_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF (2015) Role of homocysteine in the development of cardiovascular disease. Nutr J 14:6. https:\/\/doi.org\/10.1186\/1475-2891-14-6","journal-title":"Nutr J"},{"key":"2710_CR36","doi-asserted-by":"publisher","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","volume":"136","author":"H Refsum","year":"2006","unstructured":"Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, Tverdal A, Tell GS, Nygard O, Vollset SE (2006) The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 136:1731S\u20131740S. https:\/\/doi.org\/10.1093\/jn\/136.6.1731S","journal-title":"J Nutr"},{"key":"2710_CR37","doi-asserted-by":"publisher","first-page":"e0282153","DOI":"10.1371\/journal.pone.0282153","volume":"18","author":"T Ohmichi","year":"2023","unstructured":"Ohmichi T, Kasai T, Shinomoto M, Kitani-Morii F, Fujino Y, Menjo K, Mizuno T (2023) Serum leucine-rich alpha2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson\u2019s disease. PLoS ONE 18:e0282153. https:\/\/doi.org\/10.1371\/journal.pone.0282153","journal-title":"PLoS ONE"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-024-02710-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T04:51:05Z","timestamp":1745297465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-024-02710-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2710"],"URL":"https:\/\/doi.org\/10.1007\/s13760-024-02710-x","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was approved by the Ethical Committee of Jinjiang Municipal Hospital and performed conforming to the guidelines of the Declaration of Helsinki, and all participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no financial interests to disclose in relation to this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial interest statement"}},{"value":"The authors have no conflicts of interest to disclose in relation to this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}